血液透析自我管理干预随机试验(HED-SMART):一种提高透析患者依从性和临床指标的实用低强度干预
HED-SMART 是一项多中心、盲法整群随机对照试验,纳入 235 例维持性血液透析患者,评估基于问题解决和社会学习理论的小组自我管理培训(4 次课程)与常规护理的效果。结果显示干预组在 3 次评估中透析间期体重增长均较基线显著降低(P<0.001),3 个月时矿物质指标改善(P<0.001),9 个月时血钾改善(P<0.001),但血磷改善未维持。干预组自我报告依从性、自我管理技能和自我效能所有时间点均显著优于对照组。
要点
- HED-SMART 可显著降低透析间期体重增长,并改善血钾和血磷等临床指标。
- 干预组自我报告依从性、自我管理技能和自我效能在各时间点均显著优于常规护理。
- 该低强度小组干预具有可行性,可作为常规护理的补充。
核心结论
- HED-SMART 为改善血液透析患者健康提供了一种有效且实用的模型。
- 观察到的临床指标和自我报告依从性改善若能在更长随访中维持,可能显著减少终末期肾病相关并发症。
研究设计与样本
- 多中心平行(1:1)设计、盲法整群随机对照试验。
- 纳入 14 个透析中心的维持性血液透析患者,共 235 例(干预组 n=134,对照组 n=101),应答率 44.2%,82.1% 完成方案。
主要发现
- 干预组透析间期体重增长在所有 3 次评估中均较基线显著降低(P<0.001);对照组除 3 个月时显著恶化外无变化。
- 干预组 3 个月时矿物质指标改善(P<0.001),9 个月时血钾浓度改善(P<0.001)。
- 干预组 3 个月时血磷浓度改善(P=0.03),但 9 个月时未维持。
- 自我报告依从性、自我管理技能和自我效能等次要结局在所有时间点均显示组间显著差异。
临床怎么用
- 可将 HED-SMART 这种低强度小组自我管理培训作为常规护理的补充,用于改善透析患者的依从性和部分临床指标。
局限性
- 糖尿病患者比例较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor adherence to treatment is common in hemodialysis patients. However, effective interventions for adherence in this population are lacking. Small studies of behavioral interventions have yielded improvements, but clinical effectiveness and long-term effects are unclear. STUDY DESIGN: Multicenter parallel (1:1) design, blinded cluster-randomized controlled trial. SETTING & PARTICIPANTS: Patients undergoing maintenance hemodialysis enrolled in 14 dialysis centers. INTERVENTION: Dialysis shifts of eligible patients were randomly assigned to either an interactive and targeted self-management training program (HED-SMART; intervention; n=134) or usual care (control; n=101). HED-SMART, developed using the principles of problem solving and social learning theory, was delivered in a group format by health care professionals over 4 sessions. OUTCOMES & MEASUREMENTS: Serum potassium and phosphate concentrations, interdialytic weight gains (IDWGs), self-reported adherence, and self-management skills at 1 week, 3 months, and 9 months postintervention. RESULTS: 235 participants were enrolled in the study (response rate, 44.2%), and 82.1% completed the protocol. IDWG was significantly lowered across all 3 assessments relative to baseline (P<0.001) among patients randomly assigned to HED-SMART. In contrast, IDWG in controls showed no change except at 3 months, when it worsened significantly. Improvements in mineral markers were noted in the HED-SMART arm at 3 months (P<0.001) and in potassium concentrations (P<0.001) at 9 months. Phosphate concentrations improved in HED-SMART at 3 months (P=0.03), but these effects were not maintained at 9 months postintervention. Significant differences between the arms were found for the secondary outcomes of self-reported adherence, self-management skills, and self-efficacy at all time points. LIMITATIONS: Low proportion of patients with diabetes. CONCLUSIONS: HED-SMART provides an effective and practical model for improving health in hemodialysis patients. The observed improvements in clinical markers and self-report adherence, if maintained at the longer follow-up, could significantly reduce end-stage renal disease-related complications. Given the feasibility of this kind of program, it has strong potential for supplementing usual care. TRIAL REGISTRATION: Registered at ISRCTN with study number ISRCTN31434033.
引用
- Griva K, Nandakumar M, Ng JH, et al. Hemodialysis Self-management Intervention Randomized Trial (HED-SMART): A Practical Low-Intensity Intervention to Improve Adherence and Clinical Markers in Patients Receiving Hemodialysis. Am J Kidney Dis. 2017. PMID: 29198641. doi:10.1053/j.ajkd.2017.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。